| Eradication of melanomas by targeted elimination of a minor subset of tumor cells P Schmidt, C Kopecky, A Hombach, P Zigrino, C Mauch, H Abken Proceedings of the National Academy of Sciences 108 (6), 2474-2479, 2011 | 142 | 2011 |
| Regression of metastatic melanoma by targeting cancer stem cells M Schlaak, P Schmidt, C Bangard, P Kurschat, C Mauch, H Abken Oncotarget 3 (1), 22, 2012 | 79 | 2012 |
| Cost of decentralized CAR T‐cell production in an academic nonprofit setting T Ran, SB Eichmüller, P Schmidt, M Schlander International journal of cancer 147 (12), 3438-3445, 2020 | 71 | 2020 |
| Idelalisib for optimized CD19‐specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients S Stock, R Übelhart, ML Schubert, F Fan, B He, JM Hoffmann, L Wang, ... International journal of cancer 145 (5), 1312-1324, 2019 | 71 | 2019 |
| The proteasome inhibitor bortezomib sensitizes melanoma cells toward adoptive CTL attack JM Seeger, P Schmidt, K Brinkmann, AA Hombach, O Coutelle, P Zigrino, ... Cancer research 70 (5), 1825-1834, 2010 | 70 | 2010 |
| Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backbone C Krug, K Birkholz, A Paulus, M Schwenkert, P Schmidt, N Hoffmann, ... Cancer Immunology, Immunotherapy 64, 1623-1635, 2015 | 55 | 2015 |
| A nonviral, nonintegrating DNA nanovector platform for the safe, rapid, and persistent manufacture of recombinant T cells M Bozza, A De Roia, MP Correia, A Berger, A Tuch, A Schmidt, I Zörnig, ... Science advances 7 (16), eabf1333, 2021 | 51 | 2021 |
| Engineered T cells for the adoptive therapy of B-cell chronic lymphocytic leukaemia P Koehler, P Schmidt, AA Hombach, M Hallek, H Abken Advances in hematology 2012, 2012 | 39 | 2012 |
| The beating heart of melanomas: a minor subset of cancer cells sustains tumor growth P Schmidt, H Abken Oncotarget 2 (4), 313, 2011 | 24 | 2011 |
| 1603P Can we reduce the acquisition cost of CAR T cell therapies? M Schlander, T Ran, P Schmidt, SB Eichmüller Annals of Oncology 31, S966, 2020 | 4 | 2020 |
| CNNParted: An open source framework for efficient convolutional neural network inference partitioning in embedded systems F Kreß, V Sidorenko, P Schmidt, J Hoefer, T Hotfilter, I Walter, T Harbaum, ... Computer Networks 229, 109759, 2023 | 2 | 2023 |
| Letscope: Lifecycle extensions through software-defined predictive control of power electronics A Chu, CM Hermann, J Silz, J Pfau, KM Barón, N Anantharajaiah, ... IEEE EUROCON 2023-20th International Conference on Smart Technologies, 665-670, 2023 | 1 | 2023 |
| An Analytical Model of Configurable Systolic Arrays to find the Best-Fitting Accelerator for a given DNN Workload T Hotfilter, P Schmidt, J Höfer, F Kreß, T Harbaum, J Becker Proceedings of the DroneSE and RAPIDO: System Engineering for constrained …, 2023 | 1 | 2023 |
| Abstract B067: Successful immunotherapy of cancer stem cells requires memory and the adaptive immune system of the host P Schmidt, N Desbaillets, P Dessen, N Thompson, J Huelsken, D Jäger Cancer Immunology Research 4 (1_Supplement), B067-B067, 2016 | 1 | 2016 |
| From Bench to Bedside: MR-HIFU-Ablation der Facettengelenke: von der präklinischen Entwicklung zur klinischen Therapie P Schmidt, G Bratke, SY Yeo, D Maintz, H Grüll RöFo-Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden …, 2024 | | 2024 |
| From bench to bedside: MR-HIFU bei Pankreaskarzinom in präklinischer und klinischer Anwendung. P Schmidt, G Bratke, SY Yeo, D Maintz, H Grüll RöFo-Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden …, 2024 | | 2024 |
| Identification of tumor-reactive T cell receptors through functional single cell interaction analyses for personalized T cell therapy TR Wagner, N Kehl, S Steiger, M Kilian, B Schönfelder, T Boschert, ... Cancer Research 84 (6_Supplement), 14-14, 2024 | | 2024 |
| Cancer therapy involving car-engineered t-cells and parvovirus h-1 N Halama, D Jäger, P Schmidt US Patent App. 18/459,879, 2024 | | 2024 |
| Personalized Immunotherapy: Advancing processes to extend patient collectives P Schmidt, SB Eichmüller, YF Sun, J Scolnick Frontiers Media SA, 2024 | | 2024 |
| MediMer: a versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection M Meyer, C Parpoulas, T Barthélémy, JP Becker, P Charoentong, Y Lyu, ... Frontiers in Immunology 14, 1294565, 2024 | | 2024 |
Michael HallekUniversity of Cologne確認したメール アドレス: uni-koeln.de
